Attached files

file filename
EX-12.1 - EXHIBIT 12.1 - Edwards Lifesciences Corpex-12110xkq42017.htm
EX-32 - EXHIBIT 32 - Edwards Lifesciences Corpex-3210xkq42017.htm
EX-31.2 - EXHIBIT 31.2 - Edwards Lifesciences Corpex-31210xkq42017.htm
EX-31.1 - EXHIBIT 31.1 - Edwards Lifesciences Corpex-31110xkq42017.htm
EX-21.1 - EXHIBIT 21.1 - Edwards Lifesciences Corpex-21110xkq42017.htm
EX-10.35 - EXHIBIT 10.35 - Edwards Lifesciences Corpex-103510xkq42017.htm
EX-10.34 - EXHIBIT 10.34 - Edwards Lifesciences Corpex-103410xkq42017.htm
EX-10.33 - EXHIBIT 10.33 - Edwards Lifesciences Corpex-103310xkq42017.htm
EX-10.27 - EXHIBIT 10.27 - Edwards Lifesciences Corpex-102710xkq42017.htm
10-K - 10-K - Edwards Lifesciences Corpew10-kq42017.htm


Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-33054, 333-33056, 333-40434, 333-52332, 333-52334, 333-52346, 333-60670, 333-98219, 333-105961, 333-127260, 333-150810, 333-154242, 333-168462, 333-183106, 333-192229, 333-195853, 333-204180, 333-211333, and 333-217909) and Form S-3 (No. 333-213358) of Edwards Lifesciences Corporation of our report dated February 16, 2018 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.


/s/ PricewaterhouseCoopers LLP
Irvine, California
February 16, 2018